Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

A Phase 2, Multicenter Open-Label Extension Study to Evaluate the Long-term Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizures

Inclusion Criteria:

• Subjects completed Study YKP3089C035 by SK Life Science.

Exclusion Criteria:

• Subjects that have previously discontinued for any reason from the Core study (YKP3089C035).
• Any significant changes to the medical history of the subject that in the opinion of the investigator, could affect the safety of the subject.